- Home
- SSB vs QGEN Comparison
SSB vs QGEN Comparison
Compare SSB & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSB | QGEN |
|---|---|---|
| Founded | 1933 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.2B |
| IPO Year | 2008 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SSB | QGEN |
|---|---|---|
| Price | $100.50 | $41.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $118.54 | $50.26 |
| AVG Volume (30 Days) | 754.7K | ★ 1.3M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | 2.40% | ★ 5.84% |
| EPS Growth | ★ 12.91 | N/A |
| EPS | ★ 7.87 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.07 | $8.18 |
| Revenue Next Year | $6.51 | $5.71 |
| P/E Ratio | ★ $12.68 | $24.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $83.92 | $38.80 |
| 52 Week High | $108.46 | $57.82 |
Technical Indicators
Market Signals| Indicator | SSB | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 65.87 | 44.85 |
| Support Level | $98.20 | $38.80 |
| Resistance Level | $101.86 | $48.53 |
| Average True Range (ATR) | 1.80 | 0.79 |
| MACD | 0.83 | 0.34 |
| Stochastic Oscillator | 94.79 | 53.32 |
Price Performance
Historical ComparisonAbout SSB SouthState Corporation
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).